511 related articles for article (PubMed ID: 19124346)
21. Safe use of long-acting β-agonists: what have we learnt?
Sears MR
Expert Opin Drug Saf; 2011 Sep; 10(5):767-78. PubMed ID: 21521133
[TBL] [Abstract][Full Text] [Related]
22. Update on the safety of long-acting beta-agonists in combination with inhaled corticosteroids for the treatment of asthma.
Nelson HS; Carr W; Nathan R; Portnoy JM
Ann Allergy Asthma Immunol; 2009 Jan; 102(1):11-5. PubMed ID: 19205279
[TBL] [Abstract][Full Text] [Related]
23. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
25. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.
Nelson HS; Weiss ST; Bleecker ER; Yancey SW; Dorinsky PM;
Chest; 2006 Jan; 129(1):15-26. PubMed ID: 16424409
[TBL] [Abstract][Full Text] [Related]
26. Safety of long-acting β agonists for the treatment of asthma: clearing the air.
Rodrigo GJ; Castro-Rodríguez JA
Thorax; 2012 Apr; 67(4):342-9. PubMed ID: 21515554
[TBL] [Abstract][Full Text] [Related]
27. Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline.
Inoue H; Komori M; Matsumoto T; Fukuyama S; Matsumura M; Nakano T; Tsuda M; Matsumoto K; Kanaya A; Moriwaki A; Aizawa H; Yoshida M; Nakanishi Y
Respiration; 2007; 74(6):611-6. PubMed ID: 16960440
[TBL] [Abstract][Full Text] [Related]
28. The risk of asthma mortality with inhaled long acting beta-agonists.
Wijesinghe M; Perrin K; Harwood M; Weatherall M; Beasley R
Postgrad Med J; 2008 Sep; 84(995):467-72. PubMed ID: 18940948
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of combined treatment with corticosteroids and beta2 agonists in adults with asthma].
ten Hacken NH; Kerstjens HA; Postma DS
Ned Tijdschr Geneeskd; 2006 Apr; 150(16):892-7. PubMed ID: 16686088
[TBL] [Abstract][Full Text] [Related]
30. New developments in bronchodilator therapy.
Nelson HS
Curr Opin Pulm Med; 1996 Jan; 2(1):35-9. PubMed ID: 9363113
[TBL] [Abstract][Full Text] [Related]
31. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
[TBL] [Abstract][Full Text] [Related]
32. Novel bronchodilators in asthma.
Cazzola M; Segreti A; Matera MG
Curr Opin Pulm Med; 2010 Jan; 16(1):6-12. PubMed ID: 19816179
[TBL] [Abstract][Full Text] [Related]
33. Beta-2 agonist discussions in asthma and a review of current data.
Erdinç M
Tuberk Toraks; 2011; 59(2):205-12. PubMed ID: 21740399
[TBL] [Abstract][Full Text] [Related]
34. Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells.
Kaur M; Chivers JE; Giembycz MA; Newton R
Mol Pharmacol; 2008 Jan; 73(1):203-14. PubMed ID: 17901197
[TBL] [Abstract][Full Text] [Related]
35. The use of beta-agonists and the risk of death and near death from asthma.
Spitzer WO; Suissa S; Ernst P; Horwitz RI; Habbick B; Cockcroft D; Boivin JF; McNutt M; Buist AS; Rebuck AS
N Engl J Med; 1992 Feb; 326(8):501-6. PubMed ID: 1346340
[TBL] [Abstract][Full Text] [Related]
36. Effect of long-acting beta2 agonists on exacerbation rates of asthma in children.
Bisgaard H
Pediatr Pulmonol; 2003 Nov; 36(5):391-8. PubMed ID: 14520721
[TBL] [Abstract][Full Text] [Related]
37. Benefit-risk assessment of long-acting beta2-agonists in asthma.
Jackson CM; Lipworth B
Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
[TBL] [Abstract][Full Text] [Related]
38. [Role of long-acting beta-agonists in the treatment of asthma].
Marti C; Janssens JP; Rutschmann O
Rev Med Suisse; 2008 Oct; 4(175):2203-4, 2206-7. PubMed ID: 19024574
[TBL] [Abstract][Full Text] [Related]
39. [Combined therapy ICS/LABA--new therapeutical trends in patients with asthma and chronic obstructive pulmonary disease].
Chazan R
Pol Merkur Lekarski; 2010 Apr; 28(166):251-5. PubMed ID: 20491331
[TBL] [Abstract][Full Text] [Related]
40. Safety of β2-Agonists in Asthma: Linking Mechanisms, Meta-Analyses and Regulatory Practice.
Dissanayake SB
AAPS J; 2015 May; 17(3):754-7. PubMed ID: 25712726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
